Skip to content

Curative Effect of Guilu Erxian Gum on Primary Osteoporosis of Yin Yang Deficiency Syndrome

Curative Effect of Guilu Erxian Gum on Primary Osteoporosis of Yin Yang Deficiency Syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006736
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

control group:Oral calcium carbonate D3, calcitriol
Observation group:orally administered of Guilu Erxian Gum combined with calcium carbonate D3 tablets, calcitriol

Sponsors

Qingdao Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the diagnostic criteria of Western medicine and TCM for osteoporosis; 2. Male or female, age 50-85, female natural menopause for more than 1 year; 3. The patient signed the informed consent form, was willing to accept the examination and treatment, and was able to cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: (1) Various types of metabolic bone diseases, such as osteogenesis imperfecta, osteomalacia, Cushing's syndrome, hyperprolactinemia, thyroid or parathyroid diseases, etc; (2) Secondary osteoporosis, or disuse osteoporosis caused by limb deformity and disability; (3) Patients with other serious diseases, such as brain, heart, lung, liver, kidney and hematopoietic system; (4) Those who take drugs that affect bone metabolism or have received medical treatment for osteoporosis within 12 months; (5) Those who are allergic to the study drug;

Design outcomes

Primary

MeasureTime frame
IL-18;IL-1ß;NLRP3;Caspase-1;bone density;TCM clinical symptoms;

Secondary

MeasureTime frame
renal function;Pain score;MDA;NO;liver function;Bone metabolism index;

Countries

China

Contacts

Public ContactQi Shubin
mr.qishubin@163.com13863995106

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026